VRTXVertex Pharmaceuticals Incorporated
Healthcare · BiotechnologyNasdaqStockMkt cap $134.1B
Disclosed trades
55
0 in 30d · 2 in 90d
Politicians
14
Last trade Sep 4, 2026
Buys
30
$281K at range midpoints
Sells
25
$265.5K at range midpoints
Closing price · 365 days
Nov 6, 2025 – Nov 5, 2026
Monthly buys vs sells · 24 months
Counts of disclosed transactions
- Buys
- Sells (incl. partial)
Politicians who traded it
9 hold it now Estimated
| Politician | Seat | Trades | Buys | Sells | Bought (mid) | Sold (mid) | Last trade | Est. position Estimated |
|---|---|---|---|---|---|---|---|---|
| DRo Khanna | House · CA-17 | 28 | 17 | 11 | $128K | $129K | Sep 4, 2026 | $45.5K |
| RByron Donalds | House · FL-19 | 4 | 2 | 2 | $16K | $16K | Mar 20, 2025 | $10.3K |
| RDavid J. Taylor | House · OH-02 | 3 | 1 | 2 | $8K | $16K | Aug 26, 2026 | — |
| RDiana Harshbarger | House · TN-01 | 3 | 0 | 3 | $0 | $24K | Nov 12, 2021 | — |
| RJefferson Shreve | House · IN-06 | 3 | 2 | 1 | $65K | $32.5K | May 12, 2025 | $31.5K |
| RLisa C. McClain | House · MI-09 | 3 | 1 | 2 | $8K | $16K | Jun 11, 2025 | — |
| RTommy Tuberville | Senate · AL | 3 | 1 | 2 | $8K | $16K | May 3, 2024 | $3.7K |
| DDonna E. Shalala | House · FL-27 | 2 | 1 | 1 | $8K | $8K | Jun 24, 2019 | — |
| DGreg Stanton | House · AZ-04 | 2 | 1 | 1 | $8K | $8K | Oct 24, 2023 | $591 |
| RAlan Armstrong | Senate · OK | 1 | 1 | 0 | $8K | $0 | Mar 27, 2026 | $10K |
| DDean Phillips | House · MN-03 | 1 | 1 | 0 | $8K | $0 | Dec 18, 2020 | $18.3K |
| RJulia Letlow | House · LA-05 | 1 | 1 | 0 | $8K | $0 | Oct 23, 2024 | $9.2K |
| RPeter Meijer | House · MI-03 | 1 | 0 | 1 | $0 | $8K | Jan 28, 2021 | — |
| DWilliam R. Keating | House · MA-09 | 1 | 1 | 0 | $8K | $0 | Mar 29, 2022 | $16.8K |
Recent trades
| Politician | Ticker | Asset | Type | Owner | Amount | vs S&P Estimated | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|---|
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Buy | Spouse | $1,001 - $15,000 | +13.0% | Sep 4, 2026 | Oct 7, 202633d | FilingOCR |
| RDavid J. Taylor | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Self | $1,001 - $15,000 | -7.2% | Aug 26, 2026 | Sep 5, 202610d | Filing |
| RTommy Tuberville | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | SellRestated | Joint | $1,001 - $15,000 | -16.7% | May 3, 2024 | Aug 5, 2026824d | Filing |
| RAlan Armstrong | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | Buy | Self | $1,001 - $15,000 | +14.6% | Mar 27, 2026 | Jul 21, 2026116d | Filing |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Buy | Spouse | $1,001 - $15,000 | +25.5% | Apr 24, 2026 | May 11, 202617d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Buy | Spouse | $1,001 - $15,000 | +25.5% | Apr 13, 2026 | May 11, 202628d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | PartialReview | Dependent | — | -14.4% | Mar 30, 2026 | Apr 7, 20268d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Buy | Spouse | $1,001 - $15,000 | +14.4% | Mar 23, 2026 | Apr 7, 202615d | FilingOCR |
| RDavid J. Taylor | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Self | $1,001 - $15,000 | -9.5% | Jan 29, 2026 | Feb 2, 20264d | Filing |
| RJulia Letlow | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Buy | Self | $1,001 - $15,000 | +13.7% | Oct 23, 2024 | Jan 13, 2026447d | Filing |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Partial | Spouse | $1,001 - $15,000 | -25.0% | Sep 5, 2025 | Oct 3, 202528d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO | Buy | Spouse | $1,001 - $15,000 | +24.1% | Aug 4, 2025 | Sep 9, 202536d | FilingOCR |
| RDavid J. Taylor | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Buy | Self | $1,001 - $15,000 | +20.8% | Aug 7, 2025 | Sep 2, 202526d | Filing |
| RLisa C. McClain | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Spouse | $1,001 - $15,000 | -23.4% | Jun 11, 2025 | Aug 13, 202563d | Filing |
| RLisa C. McClain | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Partial | Spouse | $1,001 - $15,000 | -23.4% | Jun 10, 2025 | Aug 13, 202564d | Filing |
| RLisa C. McClain | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Buy | Spouse | $1,001 - $15,000 | +23.4% | Dec 11, 2024 | Aug 13, 2025245d | Filing |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCoRPO CMN | Buy | Dependent | $1,001 - $15,000 | -4.2% | Jun 23, 2025 | Jul 9, 202516d | FilingOCR |
| RJefferson Shreve | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Self | $15,001 - $50,000 | -0.2% | May 12, 2025 | Jun 22, 202541d | Filing |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Partial | Spouse | $1,001 - $15,000 | +1.4% | May 28, 2025 | Jun 10, 202513d | FilingOCR |
| DRo Khanna | VRTX | VERTEX'PHARMACEUTICALS INCORPO CMN | Sell | Dependent | $1,001 - $15,000 | +1.4% | May 19, 2025 | Jun 10, 202522d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO | Buy | Spouse | $1,001 - $15,000 | -2.3% | Apr 23, 2025 | May 12, 202519d | FilingOCR |
| RByron Donalds | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Spouse | $1,001 - $15,000 | +26.6% | Mar 20, 2025 | Apr 14, 202525d | Filing |
| RByron Donalds | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Self | $1,001 - $15,000 | +26.6% | Mar 20, 2025 | Apr 14, 202525d | Filing |
| RJefferson Shreve | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Buy | Self | $15,001 - $50,000 | -25.2% | Mar 13, 2025 | Apr 11, 202529d | Filing |
| RJefferson Shreve | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Buy | Self | $15,001 - $50,000 | -22.3% | Feb 24, 2025 | Mar 9, 202513d | Filing |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Buy | Dependent | $1,001 - $15,000 | -16.3% | Feb 25, 2025 | Mar 6, 20259d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Partial | Spouse | $1,001 - $15,000 | +16.3% | Feb 19, 2025 | Mar 6, 202515d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Partial | Dependent | $1,001 - $15,000 | +8.1% | Jan 22, 2025 | Feb 6, 202515d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO | Buy | Spouse | $1,001 - $15,000 | -8.1% | Jan 17, 2025 | Feb 6, 202520d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Partial | Spouse | $1,001 - $15,000 | -7.3% | Dec 16, 2024 | Jan 8, 202523d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPQ | Buy | Dependent | $1,001 - $15,000 | -2.9% | Nov 15, 2024 | Dec 5, 202420d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Partial | Dependent | $1,001 - $15,000 | +17.6% | Oct 14, 2024 | Nov 8, 202425d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | BuyReview | Spouse | $1,001 - $15,000 | -17.6% | Oct 11, 2024 | Nov 8, 202428d | FilingOCR |
| RByron Donalds | VRTX | Vertex Pharmaceuticals (VRTX) | BuyReview | Spouse | $1,001 - $15,000 | -17.6% | Dec 7, 2022 | Nov 8, 2024702d | FilingOCR |
| RByron Donalds | VRTX | Vertex Pharmaoeuticals (VRTX) | BuyReview | Self | $1,001 - $15,000 | -17.6% | Dec 7, 2022 | Nov 8, 2024702d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Partial | Spouse | $15,001 - $50,000 | +19.7% | Aug 2, 2024 | Sep 6, 202435d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Partial | Spouse | $1,001 - $15,000 | +19.7% | Aug 2, 2024 | Sep 6, 202435d | FilingOCR |
| RTommy Tuberville | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | Sell | Joint | $1,001 - $15,000 | +22.2% | May 3, 2024 | Jun 14, 202442d | Filing |
| DGreg Stanton | VRTX | Vertex Pharmaceuticals Incorporated (VRTX) | Sell | Spouse | $1,001 - $15,000 | +21.8% | Oct 24, 2023 | Nov 9, 202316d | Filing |
| DGreg Stanton | VRTX | Vertex Pharmaceuticals Incorporated (VRTX) | Buy | Spouse | $1,001 - $15,000 | -21.8% | Sep 26, 2023 | Nov 9, 202344d | Filing |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Buy | Spouse | $1,001 - $15,000 | -6.9% | Jun 29, 2023 | Jul 11, 202312d | FilingOCR |
| DRo Khanna | VRTX | [VERTEX PHARMACEUTICALS INCORPO CMN | Buy | Dependent | $1,001 - $15,000 | -9.7% | May 23, 2023 | Jun 12, 202320d | FilingOCR |
| DRo Khanna | VRTX | [VERTEX PHARMACEUTICALS INCoRPO CMN | Buy | Dependent | $1,001 - $15,000 | -11.1% | Mar 24, 2023 | Apr 7, 202314d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Buy | Dependent | $1,001 - $15,000 | -0.7% | Jan 11, 2023 | Feb 7, 202327d | FilingOCR |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | Partial | Spouse | $15,001 - $50,000 | +1.9% | Dec 6, 2022 | Jan 6, 202331d | FilingOCR |
| RTommy Tuberville | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | Buy | Joint | $1,001 - $15,000 | -11.3% | Oct 6, 2022 | Nov 10, 202235d | Filing |
| DRo Khanna | VRTX | VERTEX PHARMACEUTICALS INCORPO CMN | BuyReview | Unknown | $1,001 - $15,000 | +3.3% | Jul 18, 2022 | Aug 9, 202222d | FilingOCR |
| DWilliam R. Keating | VRTX | Vertex Pharmaceuticals Incorporated (VRTX) | Buy | Self | $1,001 - $15,000 | +26.5% | Mar 29, 2022 | May 5, 202237d | Filing |
| RDiana Harshbarger | VRTX | VERTEX PHARMACEUTICALS INC | Sell | Self | $1,001 - $15,000 | -89.9% | Nov 12, 2021 | Dec 30, 202148d | FilingOCR |
| RDiana Harshbarger | VRTX | VERTEXPHARMACEUTICALSINC | SellReview | Self | $1,001 - $15,000 | — | — | Dec 1, 2021 | FilingOCR |
Insider activity Filed
Insiders
26
Pharmaceutical Preparations
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
0
$0 sold
Net · 90d
$0
-$158.1M net over 12 months · last Oct 20, 2026
| Date | Insider | Kind | Security | Shares | Price | Value | Post-holdings | D/I | 10b5-1 | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2026filed Oct 22, 2026 | Daniel J. Brennan | Award | Common Stock | 795 | $503.47 | $400,259 | 795 | D | — | 4 |
| Oct 15, 2026filed Oct 19, 2026 | Bruce I Sachs | Award | Deferred Stock Unitsderiv. | 92.69 | $512.44 | — | 15,864.50 | D | — | 4 |
| Oct 15, 2026filed Oct 19, 2026 | Alan M Garber | Award | Deferred Stock Unitsderiv. | 29.27 | $512.44 | — | 94.73 | D | — | 4 |
| Sep 8, 2026filed Sep 10, 2026 | Jasper Van GrunsvenEVP, CP and NPPO | Award | Common Stock | 8,682 | $0.00 | $0 | 8,682 | D | — | 4 |
| Aug 28, 2026filed Sep 1, 2026 | Kristen AmbroseSVP & Chief Accounting Officer | Award | Common Stock | 5,000 | $0.00 | $0 | 11,624 | D | — | 4 |
| Aug 27, 2026filed Aug 31, 2026 | Bruce I Sachs | Gift | Common Stock | −6,000 | $0.00 | $0 | 39,000 | D | — | 4 |
| Jul 21, 2026filed Jul 23, 2026 | Ourania TatsisEVP, Chief Reg. & Quality Off. | Award | Common Stock | 8,251 | $0.00 | $0 | 53,572 | D | — | 4 |
| Jul 21, 2026filed Jul 23, 2026 | Amit SachdevEVP Chief Patient & Ext Af Off | Award | Common Stock | 8,251 | $0.00 | $0 | 66,512 | D | — | 4 |
| Jul 15, 2026filed Jul 17, 2026 | Bruce I Sachs | Award | Deferred Stock Unitsderiv. | 99.94 | $475.28 | — | 15,771.81 | D | — | 4 |
| Jul 15, 2026filed Jul 17, 2026 | Alan M Garber | Award | Deferred Stock Unitsderiv. | 31.56 | $475.28 | — | 65.46 | D | — | 4 |
Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).
Unusual activity Estimated
- 65Insider overlapPublic Jul 21, 2026 · traded Mar 27, 2026
Sen. Alan Armstrong bought VRTX 28 days after its CEO sold $7.7M
Details
- Politician
- Alan Armstrong
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock
- Tx type
- buy
- Traded
- Mar 27, 2026
- Filed
- Jul 21, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 116
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2026-02-27","shares":15580,"price":495.38,"value":7718020.4,"is_10b5_1":true,"filing_date":"2026-03-03"}
- Days between
- 28
- Opposite side
- Yes
- Public from
- Jul 21, 2026
- Method version
- 2026-11-03
- 65Insider overlapPublic Apr 7, 2026 · traded Mar 23, 2026
Rep. Ro Khanna's spouse bought VRTX 24 days after its CEO sold $7.7M
Details
- Politician
- Ro Khanna
- Ticker
- VRTX
- Asset
- VERTEX PHARMACEUTICALS INCORPO CMN
- Tx type
- buy
- Traded
- Mar 23, 2026
- Filed
- Apr 7, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 15
- Owner type
- spouse
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2026-02-27","shares":15580,"price":495.38,"value":7718020.4,"is_10b5_1":true,"filing_date":"2026-03-03"}
- Days between
- 24
- Opposite side
- Yes
- Public from
- Apr 7, 2026
- Method version
- 2026-11-03
- 50Insider overlapPublic Mar 3, 2026 · traded Jan 29, 2026
Rep. David J. Taylor sold VRTX 29 days before its CEO sold $7.7M
Details
- Politician
- David J. Taylor
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
- Tx type
- sell
- Traded
- Jan 29, 2026
- Filed
- Feb 2, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 4
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2026-02-27","shares":15580,"price":495.38,"value":7718020.4,"is_10b5_1":true,"filing_date":"2026-03-03"}
- Days between
- -29
- Opposite side
- No
- Public from
- Mar 3, 2026
- Method version
- 2026-11-03
- 28Exec salePublic Mar 3, 2026 · traded Feb 27, 2026
VRTX CEO Reshma Kewalramani sold $7.7M (10b5-1 plan)
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Traded
- Feb 27, 2026
- Shares
- 15,580
- Price
- $495
- Value
- $7.7M
- Is 10b5 1
- Yes
- Filed
- Mar 3, 2026
- Public from
- Mar 3, 2026
- Method version
- 2026-11-03
- 65Insider overlapPublic Jan 13, 2026 · traded Oct 23, 2024
Rep. Julia Letlow bought VRTX 16 days before its CEO sold $7.8M
Details
- Politician
- Julia Letlow
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
- Tx type
- buy
- Traded
- Oct 23, 2024
- Filed
- Jan 13, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 447
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2024-11-08","shares":15198,"price":515,"value":7826970,"is_10b5_1":true,"filing_date":"2024-11-12"}
- Days between
- -16
- Opposite side
- Yes
- Public from
- Jan 13, 2026
- Method version
- 2026-11-03
- 27Exec salePublic Dec 5, 2025 · traded Dec 3, 2025
VRTX Chair Jeffrey M Leiden sold $7.1M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Traded
- Dec 3, 2025
- Shares
- 15,681
- Price
- $452
- Value
- $7.1M
- Is 10b5 1
- Yes
- Filed
- Dec 5, 2025
- Public from
- Dec 5, 2025
- Method version
- 2026-11-03
- 32Exec salePublic Nov 17, 2025 · traded Nov 14, 2025
VRTX Chair Jeffrey M Leiden sold $14.2M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Traded
- Nov 14, 2025
- Shares
- 32,234
- Price
- $440
- Value
- $14.2M
- Is 10b5 1
- Yes
- Filed
- Nov 17, 2025
- Public from
- Nov 17, 2025
- Method version
- 2026-11-03
- 29Exec salePublic Nov 17, 2025 · traded Nov 14, 2025
VRTX Chair Jeffrey M Leiden sold $9.4M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Traded
- Nov 14, 2025
- Shares
- 21,330
- Price
- $441
- Value
- $9.4M
- Is 10b5 1
- Yes
- Filed
- Nov 17, 2025
- Public from
- Nov 17, 2025
- Method version
- 2026-11-03
- 28Exec salePublic Nov 17, 2025 · traded Nov 13, 2025
VRTX Chair Jeffrey M Leiden sold $8.2M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Traded
- Nov 13, 2025
- Shares
- 18,528
- Price
- $440
- Value
- $8.2M
- Is 10b5 1
- Yes
- Filed
- Nov 17, 2025
- Public from
- Nov 17, 2025
- Method version
- 2026-11-03
- 65Insider overlapPublic Oct 3, 2025 · traded Sep 5, 2025
Rep. Ro Khanna's spouse partially sold VRTX 30 days after its CEO bought $2.2M
Details
- Politician
- Ro Khanna
- Ticker
- VRTX
- Asset
- VERTEX PHARMACEUTICALS INCORPO CMN
- Tx type
- partial_sale
- Traded
- Sep 5, 2025
- Filed
- Oct 3, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 28
- Owner type
- spouse
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_buy","tx_date":"2025-08-06","shares":5710,"price":389.95,"value":2226614.5,"is_10b5_1":false,"filing_date":"2025-08-07"}
- Days between
- 30
- Opposite side
- Yes
- Public from
- Oct 3, 2025
- Method version
- 2026-11-03